Ovid C. Amadi, PhD

Ovid C. Amadi, PhD

Managing Director, Research Analyst
Robert Aurigema

Robert Aurigema

Partner, Chief Operating Officer and Chief Financial Officer
Scott Band, CPA

Scott Band, CPA

Senior Director, Tax
Matthew Bieret

Matthew Bieret

Managing Director, Finance
Paula Boone, CPA

Paula Boone, CPA

Management Company Controller
Mike Christman

Mike Christman

Managing Director, Operations
Lauren Cuje

Lauren Cuje

Managing Director, New Ventures
Sarah Dean

Sarah Dean

Chief of Staff to President
Zach Feller, CPA

Zach Feller, CPA

Controller
Peter Fong, PhD

Peter Fong, PhD

Partner, President
Sarah Garwood

Sarah Garwood

Director, Community Engagement, RTW Foundation
Nehal Gosalia, PhD

Nehal Gosalia, PhD

Research Analyst, Director of Genetics
Sean Haggerty

Sean Haggerty

Managing Director
Julia Enright Harper

Julia Enright Harper

Director, Investor Relations & Business Development
Lorrie Herbert, CPA

Lorrie Herbert, CPA

Director of Valuations
Sam Huang

Sam Huang

Senior Tax Associate
Charlotte Jorge

Charlotte Jorge

Asset Selection Executive Assistant
Joe Katakowski Ph.D

Joe Katakowski Ph.D

Director, Research, RTW Foundation
Tera Kelley

Tera Kelley

Firm Services Executive Assistant
Joshua Kennedy-Smith, PhD

Joshua Kennedy-Smith, PhD

Partner, Research Analyst
Kristina Koskinen

Kristina Koskinen

Asset Selection Executive Assistant
Michelle Krinke

Michelle Krinke

Head Trader
Christopher Krone, CPA

Christopher Krone, CPA

Director of Finance, Family Office
Matt Lane

Matt Lane

Fund Accounting Associate
Samantha Larsen, PhD

Samantha Larsen, PhD

Associate, New Ventures
Alice Lee, JD

Alice Lee, JD

Senior Counsel
Lauren Lee, PhD

Lauren Lee, PhD

Research Analyst
Yuantao Li, PhD

Yuantao Li, PhD

Research Associate
Chris Liu, PhD

Chris Liu, PhD

Senior Research Analyst
Sabera Loughran

Sabera Loughran

Partner Emeritus, Founding COO and CFO
Paul Lu, PhD

Paul Lu, PhD

Managing Director, Head of Business Development
Gotham Makker, MD

Gotham Makker, MD

Partner, Head of Strategic Investments
John Maraganore, PhD

John Maraganore, PhD

Executive Partner
Christina Mastrangelo

Christina Mastrangelo

Executive Assistant, Family Office
Lindsay McBride

Lindsay McBride

Corporate Access Coordinator
Krisha McCune

Krisha McCune

Director, Investor Relations, RTW Biotech Opportunities
Mirabelle Mi

Mirabelle Mi

Head of China Market Research
Abdi Moazami

Abdi Moazami

Senior Director, Compliance
Sam Na

Sam Na

Senior Director of Valuations
Tony Nguyen

Tony Nguyen

Partner, Research Analyst
Michael Norman

Michael Norman

Vice President, New Ventures
Deirdre O’Donnell

Deirdre O’Donnell

Vice President, NewCo Operations
Daniela Ortega Toro

Daniela Ortega Toro

Research Specialist
David Pan

David Pan

Head of Family Office
Irene Park

Irene Park

Research Analyst
Dar Patel, JD

Dar Patel, JD

General Counsel & CCO
Danielle Petras

Danielle Petras

Executive Assistant to the Managing Partner
Teysha Popescu

Teysha Popescu

Office Manager
Piratip Pratumsuwan

Piratip Pratumsuwan

Managing Director, Research Analyst
Stefan Prendergast

Stefan Prendergast

Senior Research Analyst
Ilke Roelofse, PhD

Ilke Roelofse, PhD

Research Specialist
Kelly Scholtz

Kelly Scholtz

Marketing, IR Coordinator
Chris Seiter

Chris Seiter

Chief Corporate Finance Officer
Ryan Sherman, CPA

Ryan Sherman, CPA

Director, Finance & Operations
Shalini Sinha

Shalini Sinha

Managing Director, Head of Human Resources
Stephanie A. Sirota

Stephanie A. Sirota

Partner, Chief Business Officer
Woody Stileman

Woody Stileman

Managing Director, Business Development
Musa Sukalic

Musa Sukalic

Senior Associate, IT
Jamie Lynne Sullivan

Jamie Lynne Sullivan

Senior Talent Acquisition Associate
Lina Tseng

Lina Tseng

Asset Selection Executive Assistant
Zoe Tsuchida

Zoe Tsuchida

Senior Director, Client Service
Connor Williams

Connor Williams

Senior Research Analyst
Marti Speranza Wong

Marti Speranza Wong

President, Community Engagement, RTW Foundation
Roderick Wong, MD

Roderick Wong, MD

Managing Partner, Chief Investment Officer
Sabrina Xiao

Sabrina Xiao

Director, OMNI Research
Naveen Yalamanchi, MD

Naveen Yalamanchi, MD

Partner, Portfolio Manager
Yasee Zahedi

Yasee Zahedi

Associate Counsel
Jingqing Zhang, PhD

Jingqing Zhang, PhD

Vice President, New Ventures
Anisha Soni

Anisha Soni

Client Service Associate
Cade Himmel

Cade Himmel

Operations Associate
Devon Taylor Leaver

Devon Taylor Leaver

Senior Associate, Brand Experience
Vincent Masto, PhD

Vincent Masto, PhD

Research Associate
Paiton Marshall

Paiton Marshall

Corporate Finance Associate
Sweeny Pillot

Sweeny Pillot

Executive Assistant
Kieran McKeon

Kieran McKeon

Valuations Associate
Ram Modh

Ram Modh

Research Associate
Mari Tikoyan

Mari Tikoyan

Research Coordinator
Luna Ji, MD

Luna Ji, MD

Principal
Gabrielle Gioscia

Gabrielle Gioscia

Executive Assistant
Kayla Jones

Kayla Jones

Receptionist
Luc Ghaleb

Luc Ghaleb

Associate
Daniel (DJ) Wendler

Daniel (DJ) Wendler

Royalty Associate
Samantha Darris

Samantha Darris

Communications Manager
Sonia Mitchell

Sonia Mitchell

Director, Property Management
Annabelle Chan

Annabelle Chan

Social Media Manager

This website is not intended to offer or to promote the offer or sale of the shares (the “Shares”) of RTW Biotech Opportunities Ltd (the “Company”) in the United States or to any “U.S. persons” as defined in Regulation S (“US persons”) under the US Securities Act of 1933, as amended (the “Securities Act”). The materials contained herein are not for release, publication or distribution, directly or indirectly, in whole or in part, to any persons to whom or into or within any jurisdiction where to do so would constitute a violation of applicable law or regulation.

The information contained herein and on the pages that follow does not constitute or form a part of any offer to sell or issue, or the solicitation of any offer to purchase, subscribe for or otherwise acquire, any securities in the United States or in any jurisdiction in which, or to any person to whom, such an offer or solicitation would be unlawful.

The Company has not been and will not be registered under the US Investment Company Act of 1940, as amended (the “Investment Company Act”), and as such holders of the Shares are not and will not be entitled to the benefits of the Investment Company Act. The Shares have not been and will not be registered under the Securities Act, or with any securities regulatory authority of any state or other jurisdiction of the United States, and may not be offered, sold, resold, pledged, delivered, assigned or otherwise transferred, directly or indirectly, into or within the United States or to, or for the account or benefit of, any US Persons, except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable securities laws of any state or other jurisdiction of the United States and in a manner which would not result in the Company being required to register under the Investment Company Act. There has been and will be no public offer of the Shares in the United States. The offer and sale of the Shares have not been and will not be registered under the applicable securities laws of Australia, Canada, Japan or South Africa. Potential users of the information contained herein and on the pages that follow are requested to inform themselves about and to observe all applicable restrictions.

The information contained herein and on the pages that follow may contain forward-looking statements. Any statement other than a statement of historical fact is a forward-looking statement. Actual results may differ materially from those expressed or implied by any forward-looking statement. The Company does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. You should not place undue reliance on any forward-looking statement, which speaks only as of the date of its issuance. The Company may change these terms and conditions from time to time and any such changes will be posted on this website. Your access to this website is governed by the version of these terms and conditions then in force.

By clicking “Agree” below, you represent, warrant, undertake and agree that (1) you have read, understood and agree to be bound by the terms and conditions and other information set out herein, (2) you are permitted under applicable laws and regulations to receive the information contained herein and on the pages that follow, (3) you are either (a) located outside the United States and are not a US Person or (b) an existing shareholder of the Company who is a “qualified purchaser” as defined under the Investment Company Act and (4) you will not further transmit or send any information contained in this website to any other persons in the United States, to US Persons, or to any publications with a general circulation in the United States. If you cannot so represent, warrant, undertake and agree, you must click the button labelled “Decline” or otherwise exit this website.